Skip to main content
Premium Trial:

Request an Annual Quote

MDS Proteomics Plans Two New Service Businesses

NEW YORK, March 4 (GenomeWeb News) - MDS Proteomics plans to launch two service-based businesses and will not start new research collaborations this year, MDS said in its earnings report for the first quarter of its fiscal year 2004 today.


The new businesses "will leverage existing capabilities and assets in the rapidly growing areas of protein analysis and biomarker development," according to MDS. The company hopes they will generate near-term revenue and help MDS Proteomics become sustainable.


MDS Proteomics is currently trying to raise funding for the service businesses from partners, stakeholders, and third parties, MDS said.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.